Q1 Pandemic Defines

Armstrong Wolfe

COO Priorities for the Year Ahead

2021 will be parallel run to meet short-term needs whilst taking business to a new paradigm


A vaccine has been developed, the end game is in sight, a return to normality is now a certainty.  Expectations are high and suggested dates when we could be carried across the threshold of vaccination into normality vary from January 2021 to its spring or autumn and some less optimistic, year-end. There is understandable enthusiasm, mixed with hope and heightened expectations as this journey starts to unfold, but how many times have we thought we are 90 days away from victory and have set false horizons?

Let us face facts, be realistic, normality will not return until the end of 2021. Even with best efforts of the scientific community and then commerce to industrialise the production of a vaccine, and then treat the world, it will be a matter of many months if not years. In this context The World Health Organisation is coordinating global efforts to develop a vaccine, with an eye toward delivering two billion by the end of 2021. This is remarkable, as it typically takes 10 to 15 years to bring a vaccine to market; the fastest ever vaccine for mumps required four years in the 1960s.